Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-08-14 07:00 |
Valneva Announces PDUFA Date Extension for Chikungunya Virus Vaccine Candidate
|
English | 118.4 KB | ||
| 2023-08-14 07:00 |
Valneva annonce le report de la date-cible pour l’examen réglementaire de son c…
|
French | 143.3 KB | ||
| 2023-08-03 08:30 |
VALNEVA Déclaration d’actions et de droits de vote - 31 juillet 2023
|
French | 14.0 KB | ||
| 2023-08-03 08:30 |
VALNEVA Declaration of shares and voting rights - July 31, 2023
|
English | 14.2 KB | ||
| 2023-07-05 08:30 |
VALNEVA - Déclaration d’actions et de droits de vote : 30 juin 2023
|
French | 13.7 KB | ||
| 2023-07-05 08:30 |
VALNEVA - Declaration of shares and voting rights: June 30, 2023
|
English | 13.9 KB | ||
| 2023-06-22 07:00 |
Valneva Supervisory Board Recommends Transition from a Two-Tier Governance Mode…
|
English | 106.6 KB | ||
| 2023-06-22 07:00 |
Le conseil de surveillance de Valneva recommande un changement de son système d…
|
French | 140.0 KB | ||
| 2023-06-21 18:15 |
Valneva Announces Successful Outcome of its AGM and the Appointment of Pfizer’s…
|
English | 146.1 KB | ||
| 2023-06-21 18:15 |
Valneva annonce l’approbation des résolutions présentées à son Assemblée Généra…
|
French | 145.5 KB | ||
| 2023-06-13 07:00 |
Valneva annonce la publication dans le Lancet des résultats de Phase 3 de son c…
|
French | 176.8 KB | ||
| 2023-06-13 07:00 |
Valneva Announces Publication of its Chikungunya Vaccine Candidate Phase 3 Data…
|
English | 168.0 KB | ||
| 2023-06-07 08:00 |
VALNEVA - Déclaration d’actions et de droits de vote : 31 mai 2023
|
French | 14.8 KB | ||
| 2023-06-07 08:00 |
VALNEVA - Declaration of shares and voting rights: May 31, 2023
|
English | 15.2 KB | ||
| 2023-05-31 07:15 |
Valneva participera à différentes conférences investisseurs en juin 2023
|
French | 117.6 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
